Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for chronic pain after thoracoscopic lung surgery
ChiCTR2400091157Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Persistent postsurgical pain (PPSP) and postoperative pain comparing Liposomal bupivacaine arm with Ropivacaine arm (2 arms). Primary endpoint: Incidence of postoperative chronic pain at 3 months. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
Persistent postsurgical pain (PPSP)postoperative pain
Beyond the preview
Go deeper on ChiCTR2400091157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091157.